Soft Peripheral Contact Lens for Eye Elongation Control (SPACE):1-year Results of a Double-blinded Randomized Con-trolled Trial

Inclusion Criteria: * Subjects must be between the ages of 8 and 15 (both 8 and 15 years old). * Subject's best corrected visual acuity must be at least LogMAR 0.10 or higher in both eyes. * The subject's eyes must be healthy and normal, and "normal eyes" is defined as having the following characteristics. 1. Based on the slit-lamp examination results of the screening clinic, determined that the infection of the conjunctiva, eyelids and accessory organs was less than Grade 2 (mild). 2. No structural abnormality of the eyelid, conjunctiva or accessory organ tissue. 3. Slit lamp findings must be less than Grade 1 (mild) and the cornea must not show: edema, staining, clouding, or vascularization according to the slit lamp findings of the screening clinic. 4. No iritis. 5. There are no other active eye diseases that are not suitable for contact lens wear. * No topical eye drops are currently being used. * The subject and his/her legal representative (if the subject is under 20 years old) are willing to sign the subject's consent form. * Legal guardians of subjects under 12 years of age are willing to sign the informed consent form. * Meet the following refractive criteria determined by cycloplegic autorefraction at baseline 1. Spherical equivalent refractive error: between -0.75 and -6.00 D inclusive 2. Astigmatism: ≤-0.75 D 3. Anisometropia: \<1.00 D Exclusion criteria: * Participants with certain eye diseases that may affect their eye health or may be aggravated by the test product. * Those who are unable to comply with regular tracking and inspection. * Subject is currently participating, or has participated in another drug trial within 4 weeks prior to enrollment in this trial. * Subject has undergone any eye surgery or corneal surgery. * Subject has used systemic steroids, other systemic medications that may significantly affect vision or recovery, ophthalmic steroids, eye ointments, or pupil dilators (except for examination pupil dilators) within 2 weeks prior to trial entry. * Those who are unable to cooperate with regular tracking and inspection. * Participants with poor hygiene practices that may compromise safety during the trial or be inconsistent with the participant's best interests.